Value-Based Healthcare: Implications for Thyroid Cancer
International Journal of Endocrine Oncology · 2016
DOI: 10.2217/ije-2015-0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrine Oncology, 2016. Verfasst von Anita K Ying und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Today's delivery of care to thyroid cancer patients is complex, and costly, with uneven outcomes that can be improved. The incidence of thyroid cancer is rising and requires coordinated, multidisciplinary care with high volume centers that is not always available in our current fragmented healthcare system. To address the needs of patients, providers and payers, we believe that thyroid cancer care needs to be reexamined from the perspective of value for the patient, which is defined as the outcomes that matter to patients relative to the cost of delivering them. This paper provides recommendations based on the key principles of the value-based approach to transform the delivery of thyroid cancer care.
Zitieren
APA
Ying, A. K., Feeley, T. W., & Porter, M. E. (2016). Value-Based Healthcare: Implications for Thyroid Cancer. International Journal of Endocrine Oncology. https://doi.org/10.2217/ije-2015-0005
Vancouver
Ying AK, Feeley TW, Porter ME. Value-Based Healthcare: Implications for Thyroid Cancer. International Journal of Endocrine Oncology. 2016. doi:10.2217/ije-2015-0005
BibTeX
@article{Ying2016,
author = {Ying, Anita K and Feeley, Thomas W and Porter, Michael E},
title = {Value-Based Healthcare: Implications for Thyroid Cancer},
journal = {International Journal of Endocrine Oncology},
year = {2016},
doi = {10.2217/ije-2015-0005}
}
EUVIMED